This suggests that, under infectious conditions, the TGF-β pathway may be reprogrammed into a pro-fibrotic signaling axis, promoting pathological remodeling of the biliary microenvironment and contributing to BA progression. This evidence concerns the gene TGFB1 and breast angiosarcoma.